|Titre :||Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region (2008)|
|Auteurs :||G. DEFOSSEZ ; A. VERNEAU ; I. INGRAND ; C. SILVAIN ; P. INGRAND ; M. BEAUCHANT ; The Poitou-Charentes hepatitis C network|
|Type de document :||Article : Périodique|
|Dans :||European Journal of Gastroenterology and Hepatology (Vol.20, n°5, May 2008)|
|Article en page(s) :||367-372|
|Discipline :||MAL (Maladies infectieuses / Infectious diseases)|
Thésaurus TOXIBASEHEPATITE ; DEPISTAGE ; PLANIFICATION SANITAIRE ; EVALUATION ; ETUDE TRANSVERSALE ; PRISE EN CHARGE ; RECOMMANDATION ; EPIDEMIOLOGIE DESCRIPTIVE ; USAGER ; DIAGNOSTIC ; EVOLUTION ; CONTAMINATION
Thésaurus GéographiqueFRANCE ; POITOU-CHARENTES
BACKGROUND AND AIMS: The aim of this repeated cross-sectional survey was to document trends in screening practices, to analyze the evolution of the epidemiological characteristics of patients with newly diagnosed hepatitis C virus (HCV) infection, and to evaluate the implementation of hepatitis C management guidelines.
METHODS: Medical laboratories in Poitou-Charentes region were surveyed on serological tests for HCV infection prescribed during two 2-month periods in 1997 and 2000, and a 4-month period in 2003. An epidemiological questionnaire and a 12-month follow-up questionnaire were addressed to physicians who prescribed tests that were positive.
RESULTS: The annual screening coverage rate increased by 40% during the study period, whereas the number of positive tests fell by 53%. The estimated detection rate of new cases decreased from 43 to 26 per 100 000 inhabitants between 1997 and 2003. In 2003, 56% of serological tests were prescribed to patients who already knew that they were HCV-seropositive. The frequencies of the two main risk factors (transfusion and intravenous drug use) slightly decreased. Management of newly diagnosed patients was inappropriate in 42% of cases in 1997, 33% in 2000, and 34% in 2003; 26% of the participants at the three periods declined follow-up. Among drug users, the proportion of treated patients remained stable (17%). One-third of the drug users were lost to follow-up by their family doctor.
CONCLUSION: Campaigns to encourage HCV screening have been effective, but the number of newly diagnosed cases has fallen markedly. National campaigns targeting the general public and healthcare professionals seem to have had no impact on patient management: in particular, drug users still do not receive adequate follow-up.
|Domaine :||Drogues illicites / Illicit drugs|
|Refs biblio. :||38|
|Affiliation :||Faculty of Medicine, University Institute of Public Health ; The Poitou-Charentes Hepatitis C Network, University Hospital La Miletrie, Poitiers, France|